Druggio Logo

Druggio

Merck Biopharma

Merck Biopharma, a division of Merck & Co., is a research-focused pharmaceutical company that works in the areas of oncology, immunology, and neurology. The company's drugs are used to treat a wide range of diseases and conditions, including cancer, autoimmune disorders, infectious diseases, and cardiovascular diseases. Merck Biopharma is known for its emphasis on cutting-edge research and development in biopharmaceuticals, and it is committed to advancing treatments and therapies that improve patients' lives. Unfortunately, specific founding year information is not available.

Merck Biopharma's Drugs

Tepmetko

Approval date

2020/3/25

Ovidrel

Approval date

2016/9/28

Erbitux

Approval date

2008/7/16